BIS to Survey Pharmaceducal Industry, Supply Chains
The Bureau of Industry and Security is preparing to launch a survey of the pharmaceutical industry to gain a better understanding of the “supply chain network that underpins U.S. pharmaceutical manufacturing capabilities,” the agency said in a July 9 news…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
release. BIS will survey hundreds of U.S. manufacturers, distributors, suppliers and customers involved in the U.S. “active pharmaceutical ingredient industrial base” in part to identify supply chain vulnerabilities and better plan for potential supply shortages. The Department of Health and Human Services requested the survey.